免疫性癫痫研究进展_Journal of Epilepsy

Authors：

宋成艳 ^1,2 ,  李亚军 ^1,2

1. ;
2. ;

Corresponding author：

李亚军, Email: liyajun9@hotmail.com

Keywords：

癫痫; 免疫性癫痫; 免疫反应; 免疫治疗

DOI：

10.7507/2096-0247.20200042

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

癫痫是一种具有永久致痫倾向的慢性脑部疾病，同时具有一定的致残率和致死率。经过正规的抗癫痫治疗，临床上仍有近 1/3 的癫痫发展为耐药性癫痫，为抗癫痫药物治疗带来挑战。最新的研究证实，相当比例的耐药性癫痫为自身免疫性癫痫，免疫反应的异常激活参与其发病。免疫性癫痫是基于自身免疫性脑炎提出的概念，它是免疫介导的、通常伴有新发难治性癫痫发作、亚急性进行性认知衰退以及行为或精神功能障碍的自身免疫性疾病，此类患者脑脊液中可检测到神经元特异性相关抗体。早期免疫调节治疗除了能有效控制癫痫症状外，还可有效缓解某些癫痫综合征的发展。因此，早期进行免疫调控治疗可能成为未来免疫性癫痫治疗的关键。

Citation： 宋成艳, 李亚军. 免疫性癫痫研究进展. Journal of Epilepsy, 2020, 6(3): 232-234. doi: 10.7507/2096-0247.20200042 Copy

1.	Dahlin M, Prast-Nielsen S. The gut microbiome and epilepsy. E Bio Medicine, 2019, 44(7): 741-746.
2.	Dubey D, Pittock SJ, McKeon A. Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability. Epilepsia, 2019, 60(2): 367-369.
3.	Braakman H, van Ingen J. Can epilepsy be treated by antibiotics? J Neurol, 2018, 265(8): 1934-1936.
4.	Hauser RM, Henshall DC, Lubin FD. The epigenetics of epilepsy and its progression. Neuroscientist, 2018, 24(2): 186-200.
5.	卢燕, 刘占利. 肠道菌群和癫痫相关性研究进展. 中华全科医学, 2018, 16(09): 1550-1553.
6.	Lin Z, Si Q, Xiaoyi Z. Association between epilepsy and systemic autoimmune diseases: a meta-analysis. seizure. European Journal of Epilepsy, 2016, 41(10): 160-166.
7.	Dubey D, Singh J, Britton JW, et al. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia, 2017, (7): 1181-1189.
8.	Gozubatik-Celik G, Ozkara C, Ulusoy C, et al. Anti-neuronal autoantibodies in both drug responsive and resistant focal seizures with unknown cause. Epilepsy Research, 2017, 135(9): 131-136.
9.	Sukhvir W, Ada TG, Cornelia MJZ, et al. Neuronal antibodies in pediatric epilepsy: clinical features and long-term outcomes of ahistorical cohort not treated with immunotherapy. Epilepsia, 2016, 57(5): 823-831.
10.	Bien CG, Holtkamp M. “Autoimmune Epilepsy”: encephalitis with autoantibodies for epileptologists. Epilepsy Curr, 2017, 17(3): 134-141.
11.	Husari KS, Dubey D. Autoimmune epilepsy. Neurotherapeutics, 2019, 16(3): 685-702.
12.	Frazzini V, Nguyen-Michel VH, Habert MO, et al. Focal status epilepticus in anti-Hu encephalitis. Autoimmun Rev, 2019, 9: 102388.
13.	Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain, 2016, 139(Pt 4): 1079-1093.
14.	Lu Y, Wang Y, Wu X, et al. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: a follow-up study in East China. Journal of clinical neuroscience, 2019, 68(10): 73-79.
15.	LV R J. Clinical analysis of 42 autoimmune epilepsy patients with autoantibody. China Medical Abstracts(Internal Medicine), 2018, 35(3): 188.
16.	Tecellioglu M, Kamisli O, Kamisli S, et al. Neurological autoantibodies in drug-resistant epilepsy of unknown cause. Ir J Med Sci, 2018, 187(4): 1057-1063.
17.	Tezer F I, Firat A, Tuzun E, et al. Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis. International Journal of Neuroscience, 2018, (5): 421-428.
18.	de Timary P, Stärkel P, Delzenne NM, et al. A role for the peripheral immune system in the development of alcohol use disorders? Neuropharmacology, 2017, 122(8): 148-160.
19.	Wang H, Wang Y. Gut microbiota-brain axis. Chinese Medical Journal, 2016, 19(1): 2373-2380.
20.	Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy. Acta Neuropathologica, 2016, (2): 211-234.
21.	Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites. Nature, 2018, 557(7707): 724-728.
22.	Stephenson J, Nutma E, Valk P, et al. Inflammation in CNS neurodegenerative diseases. Immunology, 2018, 154(2): 204-219.
23.	Dubey D, Samudra N, Gupta P, et al. Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy. Seizure, 2015, 29(7): 143-147.
24.	Wu J, Zhang Y, Yang H, et al. Intestinal microbiota as an alternative therapeutic target for epilepsy. Can J Infect Dis Med Microbiol, 2016, 2016: 9032809.
25.	Toledano M, Britton J W, McKeon A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology, 2014, 82(18): 1578-1586.
26.	曾畅, 王冕, 张晨, 等. 自身免疫性癫痫入院诊断与免疫治疗转归的相关性. 中南大学学报(医学版), 2019, 44(8): 885-891.
27.	Seo JH, Lee YJ, Lee KH, et al. Autoimmune encephalitis and epilepsy: evolving definition and clinical spectrum. Korean J Pediatr, 2019, 16(8): 00598.
28.	Hakamifard A, Naghibi SN, Hashemi FS. Anti-NMDA receptor encephalitis presenting with status epilepticus: brucellosis as a possible triggering factor: a case report. Int J Prev Med, 2019, 10(7): 119.
29.	Gaspard N. Putting a band-aid on a broken leg: antiseizure medications are inferior to immune therapies in autoimmune epilepsy. Epilepsy Curr, 2019, 19(5): 302-304.

1. Dahlin M, Prast-Nielsen S. The gut microbiome and epilepsy. E Bio Medicine, 2019, 44(7): 741-746.
2. Dubey D, Pittock SJ, McKeon A. Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability. Epilepsia, 2019, 60(2): 367-369.
3. Braakman H, van Ingen J. Can epilepsy be treated by antibiotics? J Neurol, 2018, 265(8): 1934-1936.
4. Hauser RM, Henshall DC, Lubin FD. The epigenetics of epilepsy and its progression. Neuroscientist, 2018, 24(2): 186-200.
5. 卢燕, 刘占利. 肠道菌群和癫痫相关性研究进展. 中华全科医学, 2018, 16(09): 1550-1553.
6. Lin Z, Si Q, Xiaoyi Z. Association between epilepsy and systemic autoimmune diseases: a meta-analysis. seizure. European Journal of Epilepsy, 2016, 41(10): 160-166.
7. Dubey D, Singh J, Britton JW, et al. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia, 2017, (7): 1181-1189.
8. Gozubatik-Celik G, Ozkara C, Ulusoy C, et al. Anti-neuronal autoantibodies in both drug responsive and resistant focal seizures with unknown cause. Epilepsy Research, 2017, 135(9): 131-136.
9. Sukhvir W, Ada TG, Cornelia MJZ, et al. Neuronal antibodies in pediatric epilepsy: clinical features and long-term outcomes of ahistorical cohort not treated with immunotherapy. Epilepsia, 2016, 57(5): 823-831.
10. Bien CG, Holtkamp M. “Autoimmune Epilepsy”: encephalitis with autoantibodies for epileptologists. Epilepsy Curr, 2017, 17(3): 134-141.
11. Husari KS, Dubey D. Autoimmune epilepsy. Neurotherapeutics, 2019, 16(3): 685-702.
12. Frazzini V, Nguyen-Michel VH, Habert MO, et al. Focal status epilepticus in anti-Hu encephalitis. Autoimmun Rev, 2019, 9: 102388.
13. Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain, 2016, 139(Pt 4): 1079-1093.
14. Lu Y, Wang Y, Wu X, et al. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: a follow-up study in East China. Journal of clinical neuroscience, 2019, 68(10): 73-79.
15. LV R J. Clinical analysis of 42 autoimmune epilepsy patients with autoantibody. China Medical Abstracts(Internal Medicine), 2018, 35(3): 188.
16. Tecellioglu M, Kamisli O, Kamisli S, et al. Neurological autoantibodies in drug-resistant epilepsy of unknown cause. Ir J Med Sci, 2018, 187(4): 1057-1063.
17. Tezer F I, Firat A, Tuzun E, et al. Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis. International Journal of Neuroscience, 2018, (5): 421-428.
18. de Timary P, Stärkel P, Delzenne NM, et al. A role for the peripheral immune system in the development of alcohol use disorders? Neuropharmacology, 2017, 122(8): 148-160.
19. Wang H, Wang Y. Gut microbiota-brain axis. Chinese Medical Journal, 2016, 19(1): 2373-2380.
20. Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy. Acta Neuropathologica, 2016, (2): 211-234.
21. Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites. Nature, 2018, 557(7707): 724-728.
22. Stephenson J, Nutma E, Valk P, et al. Inflammation in CNS neurodegenerative diseases. Immunology, 2018, 154(2): 204-219.
23. Dubey D, Samudra N, Gupta P, et al. Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy. Seizure, 2015, 29(7): 143-147.
24. Wu J, Zhang Y, Yang H, et al. Intestinal microbiota as an alternative therapeutic target for epilepsy. Can J Infect Dis Med Microbiol, 2016, 2016: 9032809.
25. Toledano M, Britton J W, McKeon A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology, 2014, 82(18): 1578-1586.
26. 曾畅, 王冕, 张晨, 等. 自身免疫性癫痫入院诊断与免疫治疗转归的相关性. 中南大学学报(医学版), 2019, 44(8): 885-891.
27. Seo JH, Lee YJ, Lee KH, et al. Autoimmune encephalitis and epilepsy: evolving definition and clinical spectrum. Korean J Pediatr, 2019, 16(8): 00598.
28. Hakamifard A, Naghibi SN, Hashemi FS. Anti-NMDA receptor encephalitis presenting with status epilepticus: brucellosis as a possible triggering factor: a case report. Int J Prev Med, 2019, 10(7): 119.
29. Gaspard N. Putting a band-aid on a broken leg: antiseizure medications are inferior to immune therapies in autoimmune epilepsy. Epilepsy Curr, 2019, 19(5): 302-304.

Previous Article
脑面血管瘤病并发症状性癫痫的研究进展
Next Article
抗体介导的自身免疫性脑炎患者的癫痫特点

Journal of Epilepsy

免疫性癫痫研究进展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content